{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:07:10Z","timestamp":1792026430414,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T00:00:00Z","timestamp":1486339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T00:00:00Z","timestamp":1486339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Myeloid differentiation 1 (MD-1), a secreted protein interacting with radioprotective 105 (RP105), plays an important role in Toll-like receptor 4 (TLR4) signalling pathway. Previous studies showed that MD-1 may be restricted in the immune system. In this study, we demonstrated for the first time that MD-1 was highly expressed in both human and animal hearts. We also discovered that cardiac-specific overexpression of MD-1 significantly attenuated pressure overload-induced cardiac hypertrophy, fibrosis, and dysfunction, whereas loss of MD-1 had the opposite effects. Similar results were observed for\n                    <jats:italic>in vitro<\/jats:italic>\n                    angiotensin II-induced neonatal rat cardiomyocyte hypertrophy. The antihypertrophic effects of MD-1 under hypertrophic stimuli were associated with the blockage of MEK-ERK 1\/2 and NF-\u03baB signalling. Blocking MEK-ERK 1\/2 signalling with a pharmacological inhibitor (U0126) greatly attenuated the detrimental effects observed in MD-1 knockout cardiomyocytes exposed to angiotensin II stimuli. Similar results were observed by blocking NF-\u03baB signalling with a pharmacological inhibitor (BAY11\u20137082). Our data indicate that MD-1 inhibits cardiac hypertrophy and suppresses cardiac dysfunction during the remodelling process, which is dependent on its modulation of the MEK-ERK 1\/2 and NF-\u03baB signalling pathways. Thus, MD-1 might be a novel target for the treatment of pathological cardiac hypertrophy.\n                  <\/jats:p>","DOI":"10.1038\/srep41857","type":"journal-article","created":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T09:26:42Z","timestamp":1486373202000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Novel Protective Role of Myeloid Differentiation 1 in Pathological Cardiac Remodelling"],"prefix":"10.1038","volume":"7","author":[{"given":"Xiaojv","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianye","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajun","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,6]]},"reference":[{"key":"BFsrep41857_CR1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","volume":"65","author":"N Frey","year":"2003","unstructured":"Frey, N. & Olson, E. N. Cardiac Hypertrophy: The Good, the Bad, and the Ugly. Annu Rev Physiol. 65, 45\u201379 (2003).","journal-title":"Annu Rev Physiol."},{"key":"BFsrep41857_CR2","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/HYPERTENSIONAHA.111.00614","volume":"61","author":"DS Jiang","year":"2013","unstructured":"Jiang, D. S. et al. Role of Interferon Regulatory Factor 4 in the Regulation of Pathological Cardiac Hypertrophy. Hypertension. 61, 1193\u20131202 (2013).","journal-title":"Hypertension."},{"key":"BFsrep41857_CR3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","volume":"8","author":"AL Bui","year":"2011","unstructured":"Bui, A. L., Horwich, T. B. & Fonarow, G. C. Epidemiology and Risk Profile of Heart Failure. Nat Rev Cardiol. 8, 30\u201341 (2011).","journal-title":"Nat Rev Cardiol."},{"key":"BFsrep41857_CR4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.112.155911","volume":"127","author":"S Sidney","year":"2013","unstructured":"Sidney, S., Rosamond, W. D., Howard, V. J. & Luepker, R. V. The \u201cHeart Disease and Stroke Statistics-2013 Update\u201d and the Need for a National Cardiovascular Surveillance System. Circulation. 127, 21\u201323 (2013).","journal-title":"Circulation."},{"key":"BFsrep41857_CR5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","volume":"34","author":"T Kawai","year":"2011","unstructured":"Kawai, T. & Akira, S. Toll-Like Receptors and their Crosstalk with Other Innate Receptors in Infection and Immunity. Immunity. 34, 637\u2013650 (2011).","journal-title":"Immunity."},{"key":"BFsrep41857_CR6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nri2038","volume":"7","author":"G Trinchieri","year":"2007","unstructured":"Trinchieri, G. & Sher, A. Cooperation of Toll-like Receptor Signals in Innate Immune Defence. Nat Rev Immunol. 7, 179\u2013190 (2007).","journal-title":"Nat Rev Immunol."},{"key":"BFsrep41857_CR7","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.biocel.2009.08.002","volume":"41","author":"K Lorenz","year":"2009","unstructured":"Lorenz, K., Schmitt, J. P., Vidal, M. & Lohse, M. J. Cardiac Hypertrophy: Targeting Raf\/MEK\/ERK1\/2-signaling. Int J Biochem Cell Biol. 41, 2351\u20132355 (2009).","journal-title":"Int J Biochem Cell Biol."},{"key":"BFsrep41857_CR8","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.freeradbiomed.2005.08.002","volume":"39","author":"T Ha","year":"2005","unstructured":"Ha, T. et al. Attenuation of Cardiac Hypertrophy by Inhibiting Both mTOR and NFkappaB Activation in Vivo . Free Radic Biol Med. 39, 1570\u20131580 (2005).","journal-title":"Free Radic Biol Med."},{"key":"BFsrep41857_CR9","doi-asserted-by":"crossref","first-page":"10679","DOI":"10.1073\/pnas.0403249101","volume":"101","author":"KS Michelsen","year":"2004","unstructured":"Michelsen, K. S. et al. Lack of Toll-like Receptor 4 Or Myeloid Differentiation Factor 88 Reduces Atherosclerosis and Alters Plaque Phenotype in Mice Deficient in Apolipoprotein E. Proc Natl Acad Sci USA 101, 10679\u201310684 (2004).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep41857_CR10","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1161\/hc5001.100631","volume":"104","author":"XH Xu","year":"2001","unstructured":"Xu, X. H. et al. Toll-Like Receptor-4 is Expressed by Macrophages in Murine and Human Lipid-Rich Atherosclerotic Plaques and Upregulated by Oxidized LDL. Circulation. 104, 3103\u20133108 (2001).","journal-title":"Circulation."},{"key":"BFsrep41857_CR11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cardiores.2005.05.025","volume":"68","author":"T Ha","year":"2005","unstructured":"Ha, T. et al. Reduced Cardiac Hypertrophy in Toll-Like Receptor 4-Deficient Mice Following Pressure Overload. Cardiovasc Res. 68, 224\u2013234 (2005).","journal-title":"Cardiovasc Res."},{"key":"BFsrep41857_CR12","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/01.CIR.0000112575.66565.84","volume":"109","author":"J Oyama","year":"2004","unstructured":"Oyama, J. et al. Reduced Myocardial Ischemia-Reperfusion Injury in Toll-Like Receptor 4-Deficient Mice. Circulation. 109, 784\u2013789 (2004).","journal-title":"Circulation."},{"key":"BFsrep41857_CR13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI6709","volume":"104","author":"S Frantz","year":"1999","unstructured":"Frantz, S. et al. Toll4 (TLR4) Expression in Cardiac Myocytes in Normal and Failing Myocardium. J Clin Invest. 104, 271\u2013280 (1999).","journal-title":"J Clin Invest."},{"key":"BFsrep41857_CR14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/CIRCRESAHA.107.158220","volume":"102","author":"L Timmers","year":"2008","unstructured":"Timmers, L. et al. Toll-Like Receptor 4 Mediates Maladaptive Left Ventricular Remodeling and Impairs Cardiac Function After Myocardial Infarction. Circ Res. 102, 257\u2013264 (2008).","journal-title":"Circ Res."},{"key":"BFsrep41857_CR15","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.4049\/jimmunol.161.3.1348","volume":"161","author":"K Miyake","year":"1998","unstructured":"Miyake, K. et al. Mouse MD-1, a Molecule that is Physically Associated with RP105 and Positively Regulates its Expression. J Immunol. 161, 1348\u20131353 (1998).","journal-title":"J Immunol."},{"key":"BFsrep41857_CR16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/ni1198","volume":"6","author":"S Divanovic","year":"2005","unstructured":"Divanovic, S. et al. Negative Regulation of Toll-like Receptor 4 Signaling by the Toll-like Receptor Homolog RP105. Nat Immunol. 6, 571\u2013578 (2005).","journal-title":"Nat Immunol."},{"key":"BFsrep41857_CR17","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nsmb.2106","volume":"18","author":"SI Yoon","year":"2011","unstructured":"Yoon, S. I., Hong, M. & Wilson, I. A. An Unusual Dimeric Structure and Assembly for TLR4 Regulator RP105-MD-1. Nat Struct Mol Biol. 18, 1028\u20131035 (2011).","journal-title":"Nat Struct Mol Biol."},{"key":"BFsrep41857_CR18","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jmb.2011.09.020","volume":"413","author":"U Ohto","year":"2011","unstructured":"Ohto, U., Miyake, K. & Shimizu, T. Crystal Structures of Mouse and Human RP105\/MD-1 Complexes Reveal Unique Dimer Organization of the Toll-Like Receptor Family. J Mol Biol. 413, 815\u2013825 (2011).","journal-title":"J Mol Biol."},{"key":"BFsrep41857_CR19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1189\/jlb.0107021","volume":"82","author":"S Divanovic","year":"2007","unstructured":"Divanovic, S. et al. Regulation of TLR4 Signaling and the Host Interface with Pathogens and Danger: The Role of RP105. J Leukoc Biol. 82, 265\u2013271 (2007).","journal-title":"J Leukoc Biol."},{"key":"BFsrep41857_CR20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijcard.2016.01.100","volume":"206","author":"X Guo","year":"2016","unstructured":"Guo, X., Jiang, H. & Chen, J. RP105-PI3K-Akt Axis: A Potential Therapeutic Approach for Ameliorating Myocardial Ischemia\/Reperfusion Injury. Int J Cardiol. 206, 95\u201396 (2016).","journal-title":"Int J Cardiol."},{"key":"BFsrep41857_CR21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.yexmp.2015.12.016","volume":"100","author":"X Li","year":"2016","unstructured":"Li, X. et al. RP105 Protects Against Myocardial Ischemia-Reperfusion Injury Via Suppressing TLR4 Signaling Pathways in Rat Model. Exp Mol Pathol. 100, 281\u2013286 (2016).","journal-title":"Exp Mol Pathol."},{"key":"BFsrep41857_CR22","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ijcard.2014.07.086","volume":"176","author":"MC Louwe","year":"2014","unstructured":"Louwe, M. C. et al. RP105 Deficiency Aggravates Cardiac Dysfunction After Myocardial Infarction in Mice. Int J Cardiol. 176, 788\u2013793 (2014).","journal-title":"Int J Cardiol."},{"key":"BFsrep41857_CR23","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1182\/blood.V92.8.2815","volume":"92","author":"Y Miura","year":"1998","unstructured":"Miura, Y. et al. RP105 is Associated with MD-1 and Transmits an Activation Signal in Human B Cells. Blood. 92, 2815\u20132822 (1998).","journal-title":"Blood."},{"key":"BFsrep41857_CR24","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood.V99.5.1699","volume":"99","author":"Y Nagai","year":"2002","unstructured":"Nagai, Y. et al. Requirement for MD-1 in Cell Surface Expression of RP105\/CD180 and B-cell Responsiveness to Lipopolysaccharide. Blood. 99, 1699\u20131705 (2002).","journal-title":"Blood."},{"key":"BFsrep41857_CR25","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1016\/j.yexcr.2008.06.006","volume":"314","author":"A Gingery","year":"2008","unstructured":"Gingery, A. et al. TGF-beta Coordinately Activates TAK1\/MEK\/AKT\/NFkB and SMAD Pathways to Promote Osteoclast Survival. Exp Cell Res. 314, 2725\u20132738 (2008).","journal-title":"Exp Cell Res."},{"key":"BFsrep41857_CR26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/art.21549","volume":"54","author":"C Lopez-Pedrera","year":"2006","unstructured":"Lopez-Pedrera, C. et al. Antiphospholipid Antibodies From Patients with the Antiphospholipid Syndrome Induce Monocyte Tissue Factor Expression through the Simultaneous Activation of NF-kappaB\/Rel Proteins Via the P38 Mitogen-Activated Protein Kinase Pathway, and of the MEK-1\/ERK Pathway. Arthritis Rheum. 54, 301\u2013311 (2006).","journal-title":"Arthritis Rheum."},{"key":"BFsrep41857_CR27","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.4049\/jimmunol.165.4.1925","volume":"165","author":"RM Gorczynski","year":"2000","unstructured":"Gorczynski, R. M. et al. Regulation of Gene Expression of Murine MD-1 Regulates Subsequent T Cell Activation and Cytokine Production. J Immunol. 165, 1925\u20131932 (2000).","journal-title":"J Immunol."},{"key":"BFsrep41857_CR28","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.4049\/jimmunol.177.2.1078","volume":"177","author":"RM Gorczynski","year":"2006","unstructured":"Gorczynski, R. M., Kai, Y. & Miyake, K. MD1 Expression Regulates Development of Regulatory T Cells. J Immunol. 177, 1078\u20131084 (2006).","journal-title":"J Immunol."},{"key":"BFsrep41857_CR29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1399-0039.2004.00132.x","volume":"63","author":"S Hadidi","year":"2004","unstructured":"Hadidi, S. & Gorczynski, R. M. MD-1 Expression Regulates Direct and Indirect Allorecognition. Tissue Antigens. 63, 132\u2013141 (2004).","journal-title":"Tissue Antigens."},{"key":"BFsrep41857_CR30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cardiores.2004.01.021","volume":"63","author":"JD Molkentin","year":"2004","unstructured":"Molkentin, J. D. Calcineurin-NFAT Signaling Regulates the Cardiac Hypertrophic Response in Coordination with the MAPKs. Cardiovasc Res. 63, 467\u2013475 (2004).","journal-title":"Cardiovasc Res."},{"key":"BFsrep41857_CR31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/01.RES.88.1.88","volume":"88","author":"OF Bueno","year":"2001","unstructured":"Bueno, O. F. et al. The Dual-Specificity Phosphatase MKP-1 Limits the Cardiac Hypertrophic Response in Vitro and in Vivo . Circ Res. 88, 88\u201396 (2001).","journal-title":"Circ Res."},{"key":"BFsrep41857_CR32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCRESAHA.110.231514","volume":"108","author":"I Kehat","year":"2011","unstructured":"Kehat, I. et al. Extracellular Signal-Regulated Kinases 1 and 2 Regulate the Balance Between Eccentric and Concentric Cardiac Growth. Circ Res. 108, 176\u2013183 (2011).","journal-title":"Circ Res."},{"key":"BFsrep41857_CR33","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1006\/jmcc.2000.1135","volume":"32","author":"T Ueyama","year":"2000","unstructured":"Ueyama, T. et al. Requirement of Activation of the Extracellular Signal-Regulated Kinase Cascade in Myocardial Cell Hypertrophy. J Mol Cell Cardiol. 32, 947\u2013960 (2000).","journal-title":"J Mol Cell Cardiol."},{"key":"BFsrep41857_CR34","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/01.RES.0000038488.38975.1A","volume":"91","author":"OF Bueno","year":"2002","unstructured":"Bueno, O. F. & Molkentin, J. D. Involvement of Extracellular Signal-Regulated Kinases 1\/2 in Cardiac Hypertrophy and Cell Death. Circ Res. 91, 776\u2013781 (2002).","journal-title":"Circ Res."},{"key":"BFsrep41857_CR35","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1093\/emboj\/19.23.6341","volume":"19","author":"OF Bueno","year":"2000","unstructured":"Bueno, O. F. et al. The MEK1-ERK1\/2 Signaling Pathway Promotes Compensated Cardiac Hypertrophy in Transgenic Mice. Embo J. 19, 6341\u20136350 (2000).","journal-title":"Embo J."},{"key":"BFsrep41857_CR36","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.physiol.63.1.391","volume":"63","author":"JD Molkentin","year":"2001","unstructured":"Molkentin, J. D. & Dorn, G. N. Cytoplasmic Signaling Pathways that Regulate Cardiac Hypertrophy. Annu Rev Physiol. 63, 391\u2013426 (2001).","journal-title":"Annu Rev Physiol."},{"key":"BFsrep41857_CR37","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCULATIONAHA.106.679589","volume":"116","author":"Y Wang","year":"2007","unstructured":"Wang, Y. Mitogen-Activated Protein Kinases in Heart Development and Diseases. Circulation. 116, 1413\u20131423 (2007).","journal-title":"Circulation."},{"key":"BFsrep41857_CR38","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/41131","volume":"388","author":"R Medzhitov","year":"1997","unstructured":"Medzhitov, R., Preston-Hurlburt, P. & Janeway, C. J. A Human Homologue of the Drosophila Toll Protein Signals Activation of Adaptive Immunity. Nature. 388, 394\u2013397 (1997).","journal-title":"Nature."},{"key":"BFsrep41857_CR39","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1073\/pnas.111155798","volume":"98","author":"NH Purcell","year":"2001","unstructured":"Purcell, N. H. et al. Activation of NF-kappa B is Required for Hypertrophic Growth of Primary Rat Neonatal Ventricular Cardiomyocytes. Proc Natl Acad Sci USA 98, 6668\u20136673 (2001).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep41857_CR40","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.CIR.0000086978.95976.41","volume":"108","author":"SA Cook","year":"2003","unstructured":"Cook, S. A., Novikov, M. S., Ahn, Y., Matsui, T. & Rosenzweig, A. A20 is Dynamically Regulated in the Heart and Inhibits the Hypertrophic Response. Circulation. 108, 664\u2013667 (2003).","journal-title":"Circulation."},{"key":"BFsrep41857_CR41","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/CIRCRESAHA.111.260729","volume":"110","author":"Q Liu","year":"2012","unstructured":"Liu, Q., Chen, Y., Auger-Messier, M. & Molkentin, J. D. Interaction Between NFkappaB and NFAT Coordinates Cardiac Hypertrophy and Pathological Remodeling. Circ Res. 110, 1077\u20131086 (2012).","journal-title":"Circ Res."},{"key":"BFsrep41857_CR42","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1161\/01.CIR.0000164237.58200.5A","volume":"111","author":"C Freund","year":"2005","unstructured":"Freund, C. et al. Requirement of Nuclear factor-kappaB in Angiotensin II- and Isoproterenol-Induced Cardiac Hypertrophy in Vivo . Circulation. 111, 2319\u20132325 (2005).","journal-title":"Circulation."},{"key":"BFsrep41857_CR43","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1161\/CIRCRESAHA.108.193318","volume":"105","author":"S Hikoso","year":"2009","unstructured":"Hikoso, S. et al. The I{kappa}B Kinase {Beta}\/Nuclear Factor {kappa}B Signaling Pathway Protects the Heart From Hemodynamic Stress Mediated by the Regulation of Manganese Superoxide Dismutase Expression. Circ Res. 105, 70\u201379 (2009).","journal-title":"Circ Res."},{"key":"BFsrep41857_CR44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/CIRCRESAHA.109.202200","volume":"106","author":"P Kratsios","year":"2010","unstructured":"Kratsios, P. et al. Antioxidant Amelioration of Dilated Cardiomyopathy Caused by Conditional Deletion of NEMO\/IKKgamma in Cardiomyocytes. Circ Res. 106, 133\u2013144 (2010).","journal-title":"Circ Res."},{"key":"BFsrep41857_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molimm.2016.05.008","volume":"75","author":"H Pan","year":"2016","unstructured":"Pan, H. et al. MD-1 Deficiency Attenuates Dextran Sodium Sulfate (DSS)-induced Colitis through Modulating the Function of Colonic Lamina Propria Dendritic Cells. Mol Immunol. 75, 1\u201310 (2016).","journal-title":"Mol Immunol."},{"key":"BFsrep41857_CR46","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2337\/db11-1182","volume":"61","author":"Y Watanabe","year":"2012","unstructured":"Watanabe, Y. et al. The Radioprotective 105\/MD-1 Complex Contributes to Diet-Induced Obesity and Adipose Tissue Inflammation. Diabetes. 61, 1199\u20131209 (2012).","journal-title":"Diabetes."},{"key":"BFsrep41857_CR47","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00109-008-0423-2","volume":"87","author":"Q Tang","year":"2009","unstructured":"Tang, Q. et al. Lysosomal Cysteine Peptidase Cathepsin L Protects Against Cardiac Hypertrophy through Blocking AKT\/GSK3beta Signaling. J Mol Med (Berl). 87, 249\u2013260 (2009).","journal-title":"J Mol Med (Berl)."},{"key":"BFsrep41857_CR48","doi-asserted-by":"crossref","first-page":"13818","DOI":"10.1073\/pnas.1008397107","volume":"107","author":"H Li","year":"2010","unstructured":"Li, H. et al. Regulator of G Protein Signaling 5 Protects Against Cardiac Hypertrophy and Fibrosis During Biomechanical Stress of Pressure Overload. Proc Natl Acad Sci USA. 107, 13818\u201313823 (2010).","journal-title":"Proc Natl Acad Sci USA."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep41857.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep41857","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep41857.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T23:20:59Z","timestamp":1692660059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep41857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,6]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,3,8]]}},"alternative-id":["BFsrep41857"],"URL":"https:\/\/doi.org\/10.1038\/srep41857","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727280394.793535831","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,6]]},"assertion":[{"value":"13 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41857"}}